We also show that Miro turnover on damaged mitochondria is altered in PD patient-derived fibroblasts containing a mutation in the PARK2 gene, suggesting that correct regulation of Miro function may be disrupted in PD. This evidence concerns the gene PRKN and Parkinson disease.